Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
Rab 香叶基香叶基化:多发性骨髓瘤的新治疗靶点
基本信息
- 批准号:8988538
- 负责人:
- 金额:$ 21.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-01-01 至 2016-08-11
- 项目状态:已结题
- 来源:
- 关键词:AddressApoptosisApoptoticBindingBiologicalBiological AssayBiological ModelsBone MarrowCell DeathCell SurvivalCell physiologyCellsCellular AssayChemistryComputer AssistedDataDevelopmentDiphosphatesDiseaseDrug CombinationsDrug DesignEnzyme InhibitionEnzymesFamilyFluorescenceGenerationsGoalsHeadHealthHematologic NeoplasmsImpairmentIn VitroIndividualIsopreneKnowledgeLeadLifeMalignant - descriptorMalignant NeoplasmsMediatingMedicalModelingMolecular ProfilingMonoclonal AntibodiesMonomeric GTP-Binding ProteinsMorbidity - disease rateMultiple MyelomaPathway interactionsPatientsPlasma CellsPlayProcessProtein IsoformsProtein IsoprenylationProtein SecretionProteinsResolutionRoleSiteSmall Interfering RNASpecificityTailTherapeuticTherapeutic AgentsVesicleWorkZincbasechemical synthesiscombinatorialcytotoxiccytotoxicitydesignenzyme pathwaygeranylgeranyl pyrophosphategeranylgeranylationinhibitor/antagonistisoprenoidnew therapeutic targetnovelnovel therapeutic interventionnovel therapeuticsprotein transportresponsetherapy developmenttrafficking
项目摘要
DESCRIPTION (provided by applicant): Multiple myeloma (MM) is characterized by the proliferation of malignant plasma cells which secrete large quantities of monoclonal protein (MP). As yet, no therapeutic strategies have been developed which target MP secretion. The Rab family of small GTPases plays key roles in intracellular vesicle trafficking. Agents which impair the geranylgeranylation of Rab proteins induce apoptosis of MM cells by disrupting MP secretion, resulting in accumulation of MP within the cells and activation of the unfolded protein response pathway (UPR). Potent inhibitors of geranylgeranyltransferase II (GGTase II), the enzyme responsible for post-translationally modifying Rab proteins, have yet to be developed. In addition, little is known regarding the role of individual Rabs in regulating MP trafficking and
the effects of selectively disrupting Rab function in MM cells. The following aims are therefore proposed: 1) To develop novel inhibitors of GGTase II and 2) To explore the role of Rabs in regulating MP trafficking in MM cells. The development of novel inhibitors of GGTase II will involve computer-assisted drug design, chemical synthesis, and biological characterization. Agents will be designed and synthesized to contain three moieties: a non-hydrolysable polar head group which will interact with the pyrophosphate recognition site, a zinc-binding motif which will interact with the catalytic zinc site, and an isoprenoid or isoprenoid-like chain which will interact with the terminal isoprene site. The use of a click-chemistry approach will allow for
the generation of multiple families of novel agents. A fluorescence-based enzyme assay will be used to determine the inhibitory activity of the compounds. Additional studies will involve determining enzyme specificity, assessing the ability to selectively inhibit Rab geranylgeranylation in MM cells, evaluating the cytotoxic effects, and examining the effects on MP trafficking. To explore the role of individual Rabs in MM cells, the effects of siRNA-mediated silencing of selected Rab isoforms on key cellular processes, including MP trafficking, the UPR, and apoptosis, will be determined. This work will lead to a better understanding of the role of Rabs in MM cells and to the development of novel agents with which to treat patients with MM.
描述(由申请人提供):多发性骨髓瘤(MM)的特点是恶性浆细胞增殖,分泌大量单克隆蛋白(MP)。到目前为止,还没有针对MP分泌的治疗策略。Rab家族的小gtpase在细胞内囊泡运输中起关键作用。破坏Rab蛋白香叶酰化的药物通过破坏MP分泌诱导MM细胞凋亡,导致MP在细胞内积累并激活未折叠蛋白反应途径(UPR)。香叶基香叶基转移酶II (GGTase II)的有效抑制剂尚未开发,该酶负责翻译后修饰Rab蛋白。此外,关于个体Rabs在调节MP贩运和贩运中的作用知之甚少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah A Holstein其他文献
Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk
基于达雷妥尤单抗的四联疗法治疗符合移植资格的新诊断的具有高细胞遗传学风险的多发性骨髓瘤
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:12.8
- 作者:
Natalie S. Callander;R. Silbermann;Jonathan L. Kaufman;K. Godby;J. Laubach;T. Schmidt;Douglas W Sborov;E. Medvedova;B. Reeves;B. Dhakal;Cesar Rodriguez;S. Chhabra;A. Chari;S. Bal;Larry D. Anderson;B. Dholaria;N. Nathwani;P. Hari;Nina Shah;N. Bumma;Sarah A Holstein;Caitlin Costello;A. Jakubowiak;T. M. Wildes;R. Orlowski;K. Shain;Andrew J Cowan;H. Pei;A. Cortoos;Sharmila Patel;Thomas S. Lin;Smith Giri;Luciano J Costa;Saad Z Usmani;Paul G Richardson;P. Voorhees - 通讯作者:
P. Voorhees
Sarah A Holstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah A Holstein', 18)}}的其他基金
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma
香叶基香叶基二磷酸合酶抑制剂治疗多发性骨髓瘤
- 批准号:
10364685 - 财政年份:2021
- 资助金额:
$ 21.66万 - 项目类别:
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma
香叶基香叶基二磷酸合酶抑制剂治疗多发性骨髓瘤
- 批准号:
10600005 - 财政年份:2021
- 资助金额:
$ 21.66万 - 项目类别:
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma
香叶基香叶基二磷酸合酶抑制剂治疗多发性骨髓瘤
- 批准号:
10180333 - 财政年份:2021
- 资助金额:
$ 21.66万 - 项目类别:
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
Rab 香叶基香叶基化:多发性骨髓瘤的新治疗靶点
- 批准号:
9331012 - 财政年份:2013
- 资助金额:
$ 21.66万 - 项目类别:
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
Rab 香叶基香叶基化:多发性骨髓瘤的新治疗靶点
- 批准号:
8416249 - 财政年份:2013
- 资助金额:
$ 21.66万 - 项目类别:
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma
Rab 香叶基香叶基化:多发性骨髓瘤的新治疗靶点
- 批准号:
8600246 - 财政年份:2013
- 资助金额:
$ 21.66万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 21.66万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 21.66万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 21.66万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 21.66万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 21.66万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 21.66万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 21.66万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 21.66万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 21.66万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 21.66万 - 项目类别:














{{item.name}}会员




